Cheryl R Blanchard
CIK 1326530 · President, CEO, Director · last filed 2026-04-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.95M
Companies
7
Total Filings
64
Lifetime Open-Market Net
-$2.39M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XLO | Director | — | $9.15 | — | $0 | 1 | 2026-04-16 |
| ANIK | President, CEO, Director | 272,231 | $15.15 | $4.12M | $207.1K | 21 | 2026-03-17 |
| Vigil Neuroscience, Inc. (VIGL) Delisted | Director | 0 | $8.05 | $0 | $0 | 9 | 2025-08-05 |
| DARE | Director | — | $1.19 | — | $0 | 5 | 2023-06-21 |
| STIM | Director | 34,437 | $1.87 | $64.4K | $0 | 3 | 2020-05-28 |
| SeaSpine Holdings Corp (SPNE) Delisted | Director | 28,948 | $9.54 | $276.2K | $0 | 4 | 2018-05-31 |
| ZBH | Sr. VP, Chief Scientific Off. | 18,357 | $95.75 | $1.76M | -$2.60M | 21 | 2012-03-21 |
Recent Filings · Page 2 of 7
64 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-19 | ANIK | Grant (A) | — | $0 | EDGAR |
| 2024-03-12 | ANIK | Mixed | +36,500 | -$716.6K | EDGAR |
| 2024-03-05 | Vigil Neuroscience, Inc. (VIGL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-21 | DARE | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | Vigil Neuroscience, Inc. (VIGL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-04-28 | ANIK | Mixed | +13,675 | -$287.1K | EDGAR |
| 2023-03-14 | ANIK | Mixed | +16,849 | -$344.8K | EDGAR |
| 2023-03-10 | ANIK | Mixed | +10,187 | -$113.9K | EDGAR |
| 2023-03-03 | Vigil Neuroscience, Inc. (VIGL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-24 | DARE | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.